143 related articles for article (PubMed ID: 21851136)
21. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
24. Economic evaluation of genetic screening for Lynch syndrome in Germany.
Severin F; Stollenwerk B; Holinski-Feder E; Meyer E; Heinemann V; Giessen-Jung C; Rogowski W
Genet Med; 2015 Oct; 17(10):765-73. PubMed ID: 25569434
[TBL] [Abstract][Full Text] [Related]
25. Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting.
Clarke EV; Muessig KR; Zepp J; Hunter JE; Syngal S; Acheson LS; Wiesner GL; Peterson SK; Bergen KM; Shuster E; Davis JV; Schneider JL; Kauffman TL; Gilmore MJ; Reiss JA; Rope AF; Cook JE; Goddard KAB
Fam Cancer; 2019 Jul; 18(3):317-325. PubMed ID: 30729418
[TBL] [Abstract][Full Text] [Related]
26. Model-Based Re-Examination of the Effectiveness of Tumor/Immunohistochemistry and Direct-to-Sequencing Protocols for Lynch Syndrome Case Finding in Endometrial Cancer.
Gudgeon JM; Varner MW; Hao J; Williams MS
JCO Oncol Pract; 2021 Nov; 17(11):e1785-e1793. PubMed ID: 33886346
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
28. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics.
Bläker H; Haupt S; Morak M; Holinski-Feder E; Arnold A; Horst D; Sieber-Frank J; Seidler F; von Winterfeld M; Alwers E; Chang-Claude J; Brenner H; Roth W; Engel C; Löffler M; Möslein G; Schackert HK; Weitz J; Perne C; Aretz S; Hüneburg R; Schmiegel W; Vangala D; Rahner N; Steinke-Lange V; Heuveline V; von Knebel Doeberitz M; Ahadova A; Hoffmeister M; Kloor M;
Int J Cancer; 2020 Nov; 147(10):2801-2810. PubMed ID: 32875553
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Screening of Colorectal Cancers Is As Accurate As Postoperative Screening for Detection of Lynch Syndrome.
Harrigan J; Davis C; Chauhan M; Buckles D; Saeed A; Kennedy K; Collins DL; Olyaee M; Madan R; Bansal A
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2372-2374.e1. PubMed ID: 32428707
[TBL] [Abstract][Full Text] [Related]
30. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
[TBL] [Abstract][Full Text] [Related]
31. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
32. Population-based screening for Lynch syndrome in Western Australia.
Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B
Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394
[TBL] [Abstract][Full Text] [Related]
33. [Comprehensive application of various screening strategies of Lynch syndrome].
Gao XH; Zhang W; Liu LJ; Yan HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):684-688. PubMed ID: 31302970
[TBL] [Abstract][Full Text] [Related]
34. Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort.
Loh Z; Williams DS; Salmon L; Dow E; John T
Intern Med J; 2019 Oct; 49(10):1278-1284. PubMed ID: 30667141
[TBL] [Abstract][Full Text] [Related]
35. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.
Ramsey SD; Clarke L; Etzioni R; Higashi M; Berry K; Urban N
Ann Intern Med; 2001 Oct; 135(8 Pt 1):577-88. PubMed ID: 11601929
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
Snowsill TM; Ryan NAJ; Crosbie EJ; Frayling IM; Evans DG; Hyde CJ
PLoS One; 2019; 14(8):e0221419. PubMed ID: 31469860
[TBL] [Abstract][Full Text] [Related]
38. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
[TBL] [Abstract][Full Text] [Related]
39. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
40. Screening of colorectal cancer.
Winawer SJ
Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
